Subjective Evaluation of a Commercially Marketed Contact Lens Amongst a Subset of the Contact Lens Wearing Population
1 other identifier
interventional
50
0 countries
N/A
Brief Summary
The purpose of this study is to compare the performance of commercially marketed contact lenses to habitual contact lenses in a selected segment of the contact lens wearing population.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2009
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2009
CompletedFirst Submitted
Initial submission to the registry
November 2, 2009
CompletedFirst Posted
Study publicly available on registry
November 5, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2010
CompletedResults Posted
Study results publicly available
February 25, 2011
CompletedJuly 10, 2012
January 1, 2012
3 months
November 2, 2009
January 31, 2011
June 26, 2012
Conditions
Outcome Measures
Primary Outcomes (1)
Comfort Upon Insertion
Comfort upon insertion, as interpreted by the participant, was recorded on a questionnaire by the participant using a 10-point scale, with 1 being poor and 10 being excellent. Comfort upon insertion was assessed as a single, retrospective evaluation of 4-weeks' wear time.
4 weeks of wear
Study Arms (2)
Lotrafilcon B / Habitual
OTHERLotrafilcon B contact lenses worn first, with habitual contact lenses worn second. Both products worn bilaterally as often as is typical for habitual lenses, and in the same modality as is typical for habitual lenses, as prescribed by regular eye care practitioner, with extended wear not to exceed 6 nights.
Habitual / Lotrafilcon B
OTHERHabitual contact lenses worn first, with lotrafilcon B lenses worn second. Both products worn bilaterally as often as is typical for habitual lenses, and in the same modality as is typical for habitual lenses, as prescribed by regular eye care practitioner, with extended wear not to exceed 6 nights.
Interventions
Commercially marketed, silicone hydrogel, spherical contact lens having a recommended replacement schedule of monthly.
Habitual soft spherical contact lens having a recommended replacement schedule of 2 weeks or monthly.
Eligibility Criteria
You may qualify if:
- Habitual spherical soft contact lens wearer who wears a contact lens with a recommended replacement schedule of 2 weeks or monthly.
- Wears lenses at least 5 days per week and at least 12 hours per day.
- Removes contact lenses daily or, if prescribed by their regular eye care practitioner, sleeps overnight in contact lenses no more than 6 consecutive nights.
- Reports 2 or fewer common lens-related symptoms with current contact lenses with a frequency of "frequently" or "always".
- Able to achieve distance visual acuity of at least 20/40 in each eye at the dispense of each pair of study lenses.
- Has acceptable or optimal fit for each eye at the dispense of each pair of study lenses.
You may not qualify if:
- Eye injury or surgery within twelve weeks prior to enrollment.
- Pre-existing ocular irritation that would preclude contact lens fitting.
- Currently enrolled in any clinical trial.
- Any use of medications for which contact lens wear could be contraindicated as determined by the investigator.
- Currently sleeping in contact lenses for more than 6 consecutive nights.
- Currently wearing daily disposable contact lenses and certain protocol-specified lens brands.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- CIBA VISIONlead
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Limitations and Caveats
Participants were masked to lotrafilcon B lenses only.
Results Point of Contact
- Title
- Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs
- Organization
- CIBA VISION
Publication Agreements
- PI is Sponsor Employee
- No
- Restriction Type
- OTHER
- Restrictive Agreement
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 2, 2009
First Posted
November 5, 2009
Study Start
October 1, 2009
Primary Completion
January 1, 2010
Study Completion
January 1, 2010
Last Updated
July 10, 2012
Results First Posted
February 25, 2011
Record last verified: 2012-01